BridgeBio Pharma
BBIO
$27.83
Share price
0.32%
Change (1 day)
103.44%
Change (1 year)
Categories
EPS for BridgeBio Pharma (BBIO)
EPS in 2023 (TTM): -$3.90
According to BridgeBio Pharma 's latest financial reports the company's current EPS (TTM) is -$3.90. In 2022 the company made an earnings per share (EPS) of -$3.27 an increase over its 2021 EPS that were of -$3.91.
EPS history for BridgeBio Pharma from 2018 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.90 | 19.27% |
| 2022 | -$3.27 | -16.37% |
| 2021 | -$3.91 | 2.89% |
| 2020 | -$3.80 | 61.71% |
| 2019 | -$2.35 | 57.54% |
| 2018 | -$1.49 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -$0.27 | -93.08% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -$1.00 | -74.36% | 🇺🇸 USA |